noscript

News and Announcements

OncoSil Appoints Independent Non-Executive Director

  • Published January 21, 2016 10:19AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

21st January 2016, ASX Announcement

OncoSil Medical Limited (ASX: OSL) is pleased to announce the appointment today of Dr Chris Roberts as an Independent Non-Executive Director of the Company, with immediate effect.

Dr Robert is a highly experienced director and senior executive with 40 years’ experience in the medical innovation space. During this time he has served on the boards of a number of ASX listed companies as well as research institutions and government entities.

Dr Roberts has forged a long and successful career in the medical device sector. He was Chief Executive Officer/President of Cochlear Limited (ASX: COH) from February 2004 to August 2015. Cochlear is the global market leader in inplantable devices, such as cochlear implants, for the hearing impaired. Dr Roberts was primarily responsible for the significant increase in the Cochlear Limited’s sales from $348m in 2005 to $926m in 2015.

To read the full announcement, please click here

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now